Literature DB >> 16258285

The absence of p53 aggravates polyploidy and centrosome number abnormality induced by Aurora-C overexpression.

Stéphanie Dutertre1, Elise Hamard-Péron, Jean-Yves Cremet, Yann Thomas, Claude Prigent.   

Abstract

Aurora-C is the third member of the aurora serine/threonine kinase family and was found only in mammals. Because Aurora-C is overexpressed in many different types of cancer cells we decided to analyze the consequences of Aurora-C overexpression in human cells. We first investigated the subcellular localization of overexpressed GFP-Aurora-C in mitosis and interphase in HeLa cells. As expected, during mitosis, we found that Aurora-C mimics Aurora-B. Surprisingly, in few interphase cells, we found that Aurora-C localized to the centrosome, like Aurora-A. We then examined the phenotype generated by Aurora-C overexpression. Basically it looked similar to the phenotypes observed after overexpression of the other Aurora kinases. We observed an augmentation of polyploid cells containing more than two centrosomes. More interestingly this phenotype was aggravated in the absence of a functional p53. Although the physiological function of Aurora-C in somatic cells remains to be clarified, our results, just like for the two other Aurora kinases, raised the question of a role of Aurora-C in the development and progression of cancer especially in the presence of mutated p53.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16258285     DOI: 10.4161/cc.4.12.2172

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  12 in total

Review 1.  Cdk1, Plks, Auroras, and Neks: the mitotic bodyguards.

Authors:  Patrick Salaun; Yoann Rannou; Claude Prigent
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

2.  Localization of aurora A and aurora B kinases during interphase: role of the N-terminal domain.

Authors:  Yoann Rannou; Marie-Bérengère Troadec; Clotilde Petretti; Fabienne Hans; Stéphanie Dutertre; Stefan Dimitrov; Claude Prigent
Journal:  Cell Cycle       Date:  2008-10-26       Impact factor: 4.534

3.  Aurora-B regulates RNA methyltransferase NSUN2.

Authors:  Shiho Sakita-Suto; Akifumi Kanda; Fumio Suzuki; Sunao Sato; Takashi Takata; Masaaki Tatsuka
Journal:  Mol Biol Cell       Date:  2007-01-10       Impact factor: 4.138

4.  Empirical single-cell tracking and cell-fate simulation reveal dual roles of p53 in tumor suppression.

Authors:  Ann Rancourt; Sachiko Sato; Masahiko S Satoh
Journal:  Elife       Date:  2022-09-20       Impact factor: 8.713

5.  Haspin kinase regulates microtubule-organizing center clustering and stability through Aurora kinase C in mouse oocytes.

Authors:  Ahmed Z Balboula; Alexandra L Nguyen; Amanda S Gentilello; Suzanne M Quartuccio; David Drutovic; Petr Solc; Karen Schindler
Journal:  J Cell Sci       Date:  2016-08-25       Impact factor: 5.285

6.  Aurora kinase-C-T191D is constitutively active mutant.

Authors:  Jabbar Khan; Sanaullah Khan; Sobia Attaullah; Ijaz Ali; Shahid Niaz Khan
Journal:  BMC Cell Biol       Date:  2012-03-26       Impact factor: 4.241

7.  Reversine suppresses oral squamous cell carcinoma via cell cycle arrest and concomitantly apoptosis and autophagy.

Authors:  Ying-Ray Lee; Wei-Ching Wu; Wen-Tsai Ji; Jeff Yi-Fu Chen; Ya-Ping Cheng; Ming-Ko Chiang; Hau-Ren Chen
Journal:  J Biomed Sci       Date:  2012-01-27       Impact factor: 8.410

8.  Overexpression of active Aurora-C kinase results in cell transformation and tumour formation.

Authors:  Jabbar Khan; Frédéric Ezan; Jean-Yves Crémet; Alain Fautrel; David Gilot; Marine Lambert; Christelle Benaud; Marie-Bérengère Troadec; Claude Prigent
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

Review 9.  Functions of Aurora kinase C in meiosis and cancer.

Authors:  Suzanne M Quartuccio; Karen Schindler
Journal:  Front Cell Dev Biol       Date:  2015-08-20

Review 10.  Centrosome dysfunction contributes to chromosome instability, chromoanagenesis, and genome reprograming in cancer.

Authors:  German A Pihan
Journal:  Front Oncol       Date:  2013-11-12       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.